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Rab GTPases, by targeting to specific membrane
compartments, play essential roles in membrane
trafficking. Lipid droplets (LDs) are dynamic subcel-
lular organelles whose growth is closely linked to
obesity and hepatic steatosis. Fsp27 is shown to be
required for LD fusion and growth by enriching at
LD-LD contact sites. Here, we identify Rab8a as a
direct interactor and regulator of Fsp27 in mediating
LD fusion in adipocytes. Knockdown of Rab8a in the
livers of ob/ob mice results in the accumulation of
smaller LDs and lower hepatic lipid levels. Surpris-
ingly, it is the GDP-bound form of Rab8a that exhibits
fusion-promoting activity.We further discover AS160
as the GTPase activating protein (GAP) for Rab8a,
which forms a ternary complex with Fsp27 and
Rab8a to positively regulate LD fusion. MSS4 antag-
onizes Fsp27-mediated LD fusion activity through
Rab8a. Our results have thus revealed a mechanistic
signaling circuit controlling LD fusion and fatty liver
formation.
INTRODUCTION
Lipid droplets (LDs) are discrete subcellular organelles present in
most cell types and organisms. In addition to serving as storage
deposits for neutral lipids such as triglycerides and cholesterol,
LDs have now been recognized as dynamic organelles involved
in multiple cellular processes(Farese and Walther, 2009; Martin
and Parton, 2006; Thiam et al., 2013). The size of LDs reflects
lipid storage capacity and has been linked to the development
of obesity, diabetes, and hepatic steatosis (Yang et al., 2012).
LDs are believed to originate from the endoplasmic reticulum
(ER) and can grow from small to large ones. Growth of LDs is
achieved by several pathways, including channeling of phos-
pholipids and neutral lipids that are synthesized from ER to378 Developmental Cell 30, 378–393, August 25, 2014 ª2014 ElsevieLDs (Fei et al., 2008; Gross et al., 2011; Kadereit et al., 2008;
Szymanski et al., 2007; Xu et al., 2012b), incorporation of TAGs
and phospholipids locally synthesized into LDs (Fujimoto et al.,
2007; Krahmer et al., 2011; Kuerschner et al., 2008; Wilfling
et al., 2013, 2014), and fusion of smaller LDs into larger LDs
(Bostro¨m et al., 2007; Fei et al., 2011; Gong et al., 2011; Guo
et al., 2008). In accordance with the critical roles of LDs, proteins
that are associated with LDs are known to exert important
roles in the regulation of lipid homeostasis and the development
of diseases that are closely related to dysregulation of lipid
metabolism (Brasaemle, 2010; Greenberg et al., 2011).
The CIDE family proteins including Cidea, Cideb, and Fsp27
(also known as Cidec) play important roles in the development
of obesity, diabetes, and hepatic steatosis (Gong et al., 2009;
Xu et al., 2012a). We have recently shown that Fsp27 and Cidea
are highly enriched at LD-LD contact sites (LDCS) and mediate
atypical LD fusion and growth through lipid exchange between
contacted LDs and a directional lipid transfer from smaller to
larger LDs (Gong et al., 2011; Sun et al., 2013b). We have also
identified Plin1 as an activator of Fsp27, which can markedly in-
crease Fsp27-mediated LD fusion and growth (Sun et al., 2013a).
However, the molecular mechanism underlying Fsp27-initiated
LD fusion remains elusive.
Rab GTPases are essential regulators of membrane dynamics
and trafficking. The activity of Rab proteins is regulated by gua-
nine nucleotide exchange factors (GEFs) that convert the GDP-
bound Rabs into the GTP-bound form through the exchange of
GDP for GTP and by GTPase activating proteins (GAPs) that
convert Rabs into the GDP-form through hydrolysis of GTP
(Stenmark, 2009). Most of Rabs are activated by membrane-
specific GEFs and subsequently interact with a wide variety of
effectors. Interestingly, the GDP form of several GTPases has
also shown to positively regulate several biological processes
including neurite formation (Shirane and Nakayama, 2006) and
the translocation of mTORC1 to lysosome (Demetriades et al.,
2014; Menon et al., 2014; Tsun et al., 2013).
Rab8 is involved in many biological processes including
ciliogenesis, epithelial polarization, cholesterol trafficking, and
GLUT4 trafficking (Kanerva et al., 2013; Pera¨nen, 2011).
AS160, a GAP of Rab8a and several other Rabs (Mıˆinea et al.,r Inc.
(legend on next page)
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GLUT4 translocation in adipocytes and muscle cells (Eguez
et al., 2005; Ishikura et al., 2007; Larance et al., 2005; Sano
et al., 2003). MSS4 has a chaperone-like function by forming a
complex with nucleotide-free Rab8 and has shown to be a
slow nucleotide exchange factor and a suppressor of Rab8,
presumably through promoting GTP loading (Burton et al.,
1994; Itzen et al., 2006; Wixler et al., 2011).
Using a small interfering RNA (siRNA) screening approach,
we have identified Rab8a as an important activator of Fsp27-
mediated LD fusion and growth. Surprisingly, the GDP-bound
form of Rab8a is active in promoting LD fusion. Importantly,
adenovirus-mediated knockdown of Rab8a in ob/ob mice
results in less hepatic lipid accumulation, smaller sizes of LDs,
and reduced based and insulin-stimulated glucose levels. In
addition, we have identified AS160 as a positive and MSS4 as
a negative regulator of LD fusion and growth. Therefore, we
have uncovered a Rab8a-Fsp27-AS160-MSS4 regulatory circuit
for the fusion and growth of LDs.
RESULTS
Identification of Rab8a as an Activator of
Fsp27-Mediated LD Fusion and Growth
As Fsp27-mediated LD fusion involves complex membrane
dynamic changes including LD tethering and fusion pore forma-
tion, we hypothesized that Rab GTPases may play a role in this
process. Using a biochemical fraction combining with proteomic
approach, we have identified 12 Rabs that were associated
with the LD fraction from 3T3-L1 adipocytes (list of primers for
semiquantitative PCR analysis in Supplemental Experimental
Procedures, No. 1–12, available online). In combination with
previously identified LD-associated Rabs (Bartz et al., 2007;
Hodges and Wu, 2010), we designed siRNAs (three pairs for
each gene) against 20 Rabs and introduced them into 3T3-L1
preadipocytes 24 hr prior to Fsp27 transfection (Figure 1A).
The knockdown efficiency for each Rab was confirmed by
semiquantitative RT-PCR analysis (data not shown). The size
of LDs in Fsp27-positive cells with individual Rab knockdown
was recorded and systematically analyzed. Primary screening
showed that LDs in Rab8a knockdown/Fsp27-expressing cells
were significantly smaller than that in control cells (Figure 1B
and Figures S1A–S1C). Quantitative analysis of LD size distribu-
tion showed that LD sizes in Rab8a knockdown cells were
smaller than that of control cells with the average diameter ofFigure 1. Identification of Rab8a as an Activator of Fsp27-Mediated Li
(A) Outline of strategy to screen for lipid droplet (LD)-associated Rabs involved in
(B and C) Knockdown of Rab8a reduces the sizes of LDs in Fsp27-expressing 3T3
represent 2 mm. The diameter (0.5 mm or above) of all LDs within one cell was m
expressing Fsp27. Data represent mean ± SD (***p < 0.001).
(D) Coexpression of Rab8a with Fsp27 promotes lipid exchange. Data represent
(E) Knocking down Rab8a decreases lipid exchange rate in 3T3-L1 preadipocyte
(F) Knocking down Rab8a decreases the LD fusion rate in 3T3-L1 preadipocyte
acceptor LDs, respectively. Data represent mean ± SEM (**p < 0.01). Scale bars
(G) Rab8a expression is increased during the course of 3T3-L1 differentiation.
(H) Rab8a is highly expressed in adipose tissue.
(I–K) Knocking down Rab8a reduces the LD size (I and J) and lipid exchange rat
entiated 3T3-L1 cells by electroporation for 72 hr. Data represent mean ± SEM (
See also Figure S1.
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1C, left panel, and S1D), representing a 55% reduction in LD vol-
ume (1.39 ± 0.09 mm3 versus 3.08 ± 0.14 mm3 in Rab8a-depleted
and control cells, respectively, Figure 1C, right panel). As a nega-
tive control, knocking down Rab8b or Rab10, close homologs of
Rab8a, in Fsp27-expressing cells did not affect LD sizes (Figures
1B and S1A–S1C). Depletion of Rab8a in cells without ectopic
Fsp27 expression did not affect the sizes and numbers of LDs
(Figures 1B and S1A–S1C).
To further ascertain the functional relationship between Rab8a
and Fsp27, we expressed Rab8a alone or in combination with
Fsp27 in 3T3-L1 preadipocytes. While expression of Rab8a
alone did not affect LD sizes, coexpression of Rab8a and
Fsp27 significantly increased LD sizes (Figures S1E and S1F).
As lipid exchange is the hallmark of Fsp27-mediated LD fusion,
we measured the lipid exchange rate in Fsp27-positive 3T3-L1
preadipocytes expressing Rab8a and observed that the lipid ex-
change rate was 2-fold higher compared with that expressing
Fsp27 alone (Figures 1D and S1G). On the contrary, knocking
down Rab8a resulted in a 3-fold reduction of the lipid exchange
rate (Figure 1E). The LD fusion rate in Fsp27-expressing cells
with Rab8a knockdown was also reduced, as the duration
required for the completion of lipid transfer from smaller LDs to
larger LDs was increased dramatically in Rab8a depleted cells
(Figure 1F; Movie S1). Overall, these data suggest that Rab8a is
an important and specific activator of Fsp27-mediated LD fusion.
Next, we accessed the function of Rab8a in promoting LD
fusion and growth in differentiated 3T3-L1 adipocytes. Rab8a
expression was markedly increased during the course of adipo-
cyte differentiation, showing a similar temporal expression pro-
file to that of Fsp27 and FABP4 (Figures 1G and S1H). Tissue
profile analysis indicated that Rab8a was at highest levels in
adipose tissue (Figure 1H). When Rab8a was knocked down
(85% knockdown efficiency) in 3T3-L1 mature adipocytes, the
sizes of LDs were markedly decreased (Figures 1I, 1J, and
S1I). Depletion of Rab8a in adipocytes also resulted in a signifi-
cantly decreased lipid exchange activity (Figure 1K). As a con-
trol, depletion of Rab10 in adipocytes did not affect LD sizes or
lipid exchange (Figures 1I–1K). Therefore, Rab8a plays an impor-
tant role in controlling LD fusion and growth in adipocytes.
Liver-Specific Knockdown of Rab8a Reduces Hepatic
Lipid Accumulation in ob/ob Mice
To further evaluate the physiological role of Rab8a in controll-
ing LD sizes and lipid storage, we generated liver-specificpid Droplet Fusion and Growth
Fsp27-mediated LD fusion and growth.
-L1 preadipocytes. LDs were labeled with Bodipy 493/503 (Green). Scale bars
easured. Fifteen cells were analyzed in control and in Rab8a knockdown cells
mean ± SEM (**p < 0.01).
s expressing Fsp27. Data represent mean ± SEM (*p < 0.05).
s expressing Fsp27-GFP. Arrowheads and asterisks represent the donor and
represent 2 mm.
e (K) in adipocytes. Rab8a or Rab10 siRNAs were delivered into 7 day differ-
**p < 0.01). Scale bars represent 20 mm.
r Inc.
(legend on next page)
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mediated system. The knockdown efficiency for Rab8a was
90% and 70% in the liver of wild-type and ob/ob mice,
respectively (Figures 2A and 2B). Knockdown of Rab8a in the
liver of wild-type mice (no hepatic Fsp27 expression) did not
affect the liver cell morphology (Figure 2C) or the amount of
hepatic TAG and CE (Figures 2D and 2E), whereas its knock-
down in the liver of ob/obmice where Fsp27 is highly expressed
(Matsusue et al., 2008) resulted in the accumulation of smaller
LDs and a significant reduction of hepatic levels of TAG and
CE (Figures 2C–2F and S2A). In addition, plasma levels of TAG
and NEFA were also dramatically decreased in ob/ob mice
with a liver-specific knockdown of Rab8a (Figures 2G and 2H).
In contrast, knocking down Rab10 in the liver of ob/ob mice
did not affect LD size, hepatic TAG and CE levels, and plasma
TAG and NEFA levels (Figures S2B–2F). Of note, Rab8a knock-
down in ob/ob mice did not affect body weight and food intake
(data not shown), the morphology of WAT and BAT (Figure S2G)
or the levels of TAGs inWAT and BAT (Figure S2H). Furthermore,
ob/ob animals with Rab8a knockdown showed reduced basal
levels of plasma glucose (Figures 2I and 2J). They also had sig-
nificantly lower levels of plasma glucose after the administration
of an exogenous load of glucose compared to that of control
mice (Figure 2I). When administered with excessive amounts of
insulin, the shRab8a expressing ob/ob mice showed reduced
levels of blood glucose compared with that of control mice
(Figure 2J). Consistently, hepatic levels of phosphorylated AKT
and GSK3b in the presence of insulin were increased in ob/ob
mice with a liver-specific knockdown of Rab8a (Figure 2K), but
not that in the WAT (Figure S2I) or muscle (Figure S2J). Overall,
these data strongly indicate that Rab8a promotes LD growth
and hepatic lipid storage in an Fsp27-dependent manner.
GDP-Bound Rab8a Is Enriched at the LDCS
and Promotes LD Fusion
As Rab GTPases function as a molecular switch by alternating
between the GTP- and the GDP-bound forms, we generated
Rab8a mutants that are locked in the GTP- or GDP-bound
states (Q67L or T22N). All these mutants also contained three
nucleotide alterations in the corresponding siRNA region result-
ing in resistance to siRNA-mediated degradation. Surprisingly,
when introduced into cells stably expressing shRab8a, wild-
type and GDP-bound Rab8a (T22N), but not GTP-bound
Rab8a (Q67L), were able to restore the activity of Fsp27-depen-
dent promotion of LD growth (Figure 3A) and lipid exchange (Fig-
ure 3B). This was not due to any difference in protein expression
as wild-type Rab8a and its mutants were expressed at similarFigure 2. Liver-Specific Knockdown of Rab8a Reduces Hepatic Lipid A
(A and B) Western blots showing hepatic levels of various proteins in wild-type (A
(C) Liver morphology of wild-type and ob/ob mice that were infected with co
(AD-shRab8a). H&E, hematoxylin and eosin staining; EM, electron microscope im
(D and E) Reduced hepatic TAG and cholesterol Ester (CE) in the liver of ob/obmic
(F) LD size distribution showed the accumulation of smaller LDs in ob/ob mice w
(G and H) Reduced serum TAG and NEFA levels in ob/ob mice infected with AD
(I and J) Reduced basal and insulin stimulated glucose levels in ob/obmice with a
tests (J) were performed in ob/ob mice infected with adenovirus for 7 days. Data
(K) Increased hepatic AKT2 (Ser473) and GSK3b (Ser9) phosphorylation in ob/ob
3 min after insulin (1 unit/kg) infusion.
See also Figure S2.
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pressing Rab8a-GDP(T22N)/Fsp27 was higher than that ex-
pressing Rab8a-GTP(Q67L)/Fsp27 (Figures 3C and 3D; Movie
S2). Therefore, in contrast to most of the membrane dynamic
process, LD fusion is positively regulated by GDP-bound Rab8a.
Next, we checked the subcellular localization of Rab8a in the
absence or presence of Fsp27. In the absence of Fsp27,
Rab8a (or its GTP and GDP-bound forms) showed no particular
LD association (Figures S3B and S3C). However, when coex-
pressed with Fsp27, wild-type Rab8a, Rab8a T22N, or Rab8a
Q67L all showed certain degrees of LD association, with
Rab8a T22N having the highest levels of LD association (Figures
3E and S3D). Rab8awas also detected in the LD fraction isolated
from mature adipocytes or from Fsp27-overexpressing cells
(Figures 3F and 3G). Importantly, higher levels of Rab8a T22N
were detected in the LD fraction (Figure 3G). Next, we isolated
the cytosol, microsomal (ER-enriched), and LD fractions from
cells expressing Fsp27/Flag-Rab8a, incubated each fraction
with cell lysate containing HA-Optineurin (an effector of Rab8a
that interacts its GTP-bound form), and immunoprecipitated
down Rab8a. Low levels of Optineurin was detected in the LD
fraction, whereas higher levels of Optineurin was detected in
the microsomal fraction (Figure 3H). Therefore, Rab8a in the
LD fraction is present predominantly in its GDP-bound form. In
conclusion, these data demonstrate that Rab8a is localized to
LD in a Fsp27-dependent manner and Rab8a-GDP has higher
affinity to bind to LDs.
We further examined the levels of Rab8a and its mutants at the
LDCS. Intensive Rab8a fluorescent signal was observed at the
LDCS, overlapping well with the signal of Fsp27 (Figure 3I).
Quantitative analysis further indicates that 65.4% of LDCSs
that were Fsp27-positive had intensive Rab8a-GDP signal (Fig-
ure 3J). However, only 11.5% and 38.4% Fsp27-positive LDCSs
were positive for Rab8a-GTP (Q67L) and wild-type Rab8a,
respectively (Figure 3J). Overall, these data suggest that GDP-
bound Rab8a is highly enriched at LDCS and promotes LD
fusion.
Fsp27 Preferentially Binds to Rab8a-GDP
To explore whether there exists a physical interaction between
Fsp27 and Rab8a, we performed immunoprecipitation in the
lysates of differentiated 3T3-L1 adipocytes using antibody
against Rab8a. Fsp27 was detected in the immunoprecipitates
of Rab8a (Figure 4A). In addition, recombinant MBP-Fsp27
fusion protein, but not MBP alone, was able to pull down
GST-Rab8a in vitro, suggesting a direct interaction between
Fsp27 and Rab8a (Figure 4B). Interestingly, truncated Fsp27ccumulation in ob/ob Mice
) and ob/ob mice (B) with a liver-specific knockdown of Rab8a.
ntrol adenovirus (AD-shNC) or adenovirus containing shRNA against Rab8a
age. Scale bars represent 50 mm for H&E staining; 2 mm for EM.
e infected with AD-shRab8a. Data represent mean ± SD (*p < 0.05, **p < 0.01).
ith a liver-specific knockdown of Rab8a.
-shRab8a. Data represent mean ± SEM (**p < 0.01, ***p < 0.001).
liver-specific knockdown of Rab8a. Glucose tolerance (I) and insulin tolerance
represent mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
mice with a liver-specific knockdown of Rab8a. Liver tissues were removed
r Inc.
(legend on next page)
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capable of interacting with Rab8a (Figure 4B, lane 4). In the pres-
ence of GTPgS, a nonhydrolyzable GTP analog, the interaction
between Fsp27 andRab8awas significantly reduced (Figure 4C),
confirming the preferred interaction between Fsp27 and Rab8a-
GDP, similar to the interaction between GDI2 and Rab8a (Fig-
ure S4A). When coexpressed in 293T cells, Rab8a-GDP (T22N)
interacted with full-length Fsp27 with a higher affinity than that
of Rab8a-GTP (Q67L) (3.5-fold higher, Figure 4D), whereas
Rab8a-Q67L showed specific interaction with Optineurin (Fig-
ure S4B). The interaction between Fsp27 and Rab8a and their
association with LDs were further evaluated by fluorescence
resonance energy transfer (FRET) assay. A strong FRET effect
was detected between Rab8a and Fsp27 on the LD surface,
with higher FRET efficiency between Rab8a-GDP and Fsp27
than that between Rab8a-GTP and Fsp27 (Figure S4C). As a
negative control, no FRET was observed between ADRP and
Fsp27 (Figure S4C).
Our deletion analysis further indicated that the C-terminal re-
gion of Fsp27 (aa136–239 and aa154–239) mediated its interac-
tion with Rab8a (Figure 4E) and to have high binding affinity
to Rab8a-GDP (Figure 4F). To identify crucial aa residues on
Rab8a that mediates its interaction with Fsp27, we generated
serial mutations on the predicted putative effector domain of
Rab8a (see detail in the Supplemental Experimental Proce-
dures). We identified three amino acid residues (R69, F70, I73)
on Rab8a that were required to mediate its interaction with
Fsp27 as simultaneous mutation of R69, F70, I73 to A (RFIA) dis-
rupted Rab8a and Fsp27 interaction (Figure 4G). This mutant
was no longer localized to LDs and had lost the activity in pro-
moting Fsp27-mediated LD fusion and growth (Figures 4H, 4I,
and S4D). Overall, these data indicate that Fsp27 preferentially
binds to Rab8a-GDP and their interaction is required for Rab8a
to localize to LDs and promote LD fusion and growth.
AS160Acts as aRab8aGAP toEnhance Fsp27-Mediated
LD Fusion
Next, we sought to identify a potential Rab8a GAP that modu-
lates Fsp27-mediated LD fusion. Thus far, TBC1D1, TBC1D4
(AS160), TBC1D10 (Epi64), and TBC1D30 have been identified
as Rab8a GAPs. TBC1D1, TBC1D30, and Epi64 (TBC1D10)Figure 3. GDP-Bound Rab8a Promotes LD Fusion and Is Enriched at t
(A and B) Wild-type (WT) and GDP-bound Rab8a (T22N) but not GTP-bound Rab8
knockdown 3T3-L1 preadipocytes. siRNA-resistantWTRab8a, Q67L, or T22Nwe
(A) Data represent mean ± SD. Data were from three independent experiments.
(C and D) Increased lipid transfer and LD fusion in 3T3-L1 preadipocytes coexp
acceptor LDs, respectively. Data represent mean ± SEM (**p < 0.01).
(E) Rab8a-GDP shows stronger LD association when coexpressed with Fsp27. G
3T3-L1 preadipocytes. Boxed areas are shown at higher magnification in the ins
(F) Rab8a is present in the LD fraction of differentiated 3T3-L1 adipocytes. Five mi
as a microsomal marker. CGI58, Fsp27, and Plin1 were used as LD markers;
respectively.
(G) Rab8a-GDP has higher affinity to LDs. Biochemical fractionation experiments
(Q67L) or Rab8a-GDP (T22N).
(H) LD-associated Rab8a is primarily in its GDP-bound form. The cytosol, micro
Rab8a. Each fractionwas incubated with cell lysate containing HA-Optineurin (HA
in the immunoprecipitated products was evaluated.
(I and J) Rab8a-GDP (T22N, green) is enriched at the LDCSwhen coexpressedwith
analysis shows the percentage of WT Rab8a, Q67L, or T22N that is enriched at
See also Figure S3.
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(Chadt et al., 2008) (Figures S5A and S5B). AS160 was found to
be abundantly expressed in differentiated adipocytes and its
expression correlated well with that of Fsp27 (Figures 5A and
S5C) and Rab8a (Figure S1H). Depleting AS160 in differentiated
3T3-L1 adipocytes resulted in the accumulation of significantly
smaller LDs (Figures 5B, S5D, and S5E) and lower lipid exchange
rate (Figure 5C), suggesting that AS160 acts as a positive regu-
lator of LD fusion and growth in adipocytes.
To reaffirm the role of AS160 in modulating Fsp27 activity, we
coexpressed Fsp27 and AS160 in 3T3-L1 preadipocytes.
Coexpression of AS160 with Fsp27 significantly increased the
accumulation of larger LDs (Figures 5D, S5F, and S5G) and
increased the lipid exchange rate (Figure 5E). Inactivation of
AS160 by introducing a mutation at the catalytic arginine resi-
due (AS160 R/K mutant) (Sano et al., 2003) abrogated the
activity of AS160 in promoting LD fusion (Figures 5D, 5E,
S5F, and S5G). Interestingly, AS160 mutant harboring alteration
at the AKT-induced phosphorylation sites (4P) (Sano et al.,
2003) did not affect its function as an activator of LD fusion
(Figures 5D, 5E, S5F, and S5G). The activity of AS160 in pro-
moting LD fusion was not affected by insulin treatment either
(Figure S5H). Importantly, when coexpressed with Fsp27 in
Rab8a knockdown cells, AS160 did not display any activity in
promoting LD fusion (Figures 5F, 5G, and S5I), suggesting
that AS160 acts as a specific GAP for Rab8a to control LD
fusion in adipocytes.
The physiological role of AS160 in controlling LD growth was
further evaluated inAS160-deficient mice and in isolated primary
adipocytes. White adipocytes from AS160-deficient mice were
smaller and the volume of LDs was also significantly reduced
compared with that of wild-type white adipocytes (Figures 5H
and 5I). Consistently, the total amount of TAG from WAT of
AS160-deficient mice was lower than that of wild-typemice (Fig-
ure 5J), indicative of a reduced lipid accumulation in WAT of
AS160-deficient mice. In addition, LD sizes and lipid exchange
rate in AS160-deficient primary adipocytes were significantly
reduced compared with that in wild-type adipocytes (Figures
5K, 5L, and S5J). These data strongly indicate that deficiency
of AS160 leads to reduced LD fusion and lipid storage in
adipocytes.he LDCS
a (Q67L) restores LD growth (A) and lipid exchange activity (B) in Rab8a stable
re cotransfectedwith Fsp27 into control cells or Rab8a stable knockdown cells.
(B) Data represent mean ± SEM (*p < 0.05, **p < 0.01).
ressing Fsp27 with T22N. Arrowheads and asterisks represent the donor and
FP-Rab8a (green) or its mutants were coexpressed with Fsp27-Cherry (Red) in
ets. Scale bars represent 5 mm.
crograms of each sample was used for western blot analysis. GRP94 was used
GM130 and b-tubulin were used as a Golgi marker and a cytosol marker,
were performed using 293T cells coexpressing Fsp27 with either Rab8a-GTP
somal, and LD fractions were isolated from cells expressing Fsp27 and Flag-
-Optn). Flag-tagged Rab8awas immunoprecipitated. The amount of Optineurin
Fsp27 (Red) in 3T3-L1 preadipocytes. Scale bars represent 5 mm.Quantitative
the LDCS relative to the enrichment of Fsp27.
r Inc.
(legend on next page)
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Enriched at LDCS
We next explored the molecular mechanism underlying the
possible interplay among AS160, Rab8a, and Fsp27. We
observed that endogenous AS160 was associated with LDs in
mature adipocytes (Figure 6A) and in preadipocytes expressing
Fsp27 (Figures S6A and S6B). Biochemical fractionation also
showed that AS160 was present in the LD fraction (Figure 6B).
When AS160 was immunoprecipitated from mature adipocytes,
Fsp27 was detected in AS160 immunoprecipitates (Figure 6C).
Reciprocally, AS160 was detected in the immunoprecipitated
Fsp27 complex (Figure 6D). The interaction between Fsp27
and AS160 was also confirmed by incubating Flag-AS160 with
MBP-Fsp27 in vitro (Figure S6C).When AS160was coexpressed
with Fsp27 or its serial truncations, full-length Fsp27 (aa 1–239)
and truncated Fsp27 containing the N-terminal region (aa 1–
153) were able to pull down AS160 (Figure 6E). FRET assay
further confirmed that the N-terminal region of Fsp27 mediated
its interaction with AS160 (Figure S6D).
Functionally, the interaction between Fsp27 and AS160 was
required for AS160 to enhance LD fusion as AS160 was not
able to enhance lipid droplet fusion when coexpressing with
the C-terminal region of Fsp27 that did not interact with AS160
(Figures 6F and S6E). Furthermore, coexpressing AS160 and
Rab8a T22N did not further enhance its activity in promoting
LD fusion, suggesting that Rab8a-GDP is able to bypass the
requirement of GAP (Figures 6F and S6E). Surprisingly,
effector-binding assay bymixing lysates from cells coexpressing
AS160/Rab8a or AS160/Rab8a/Fsp27 with lysates containing
Optineurin showed that coexpressing Rab8a and AS160 did
not change the levels of Rab8a-GTP (lanes 1 and 2 in Figure 6G).
However, when AS160 was coexpressed with full-length Fsp27,
the amount of Rab8a-GTP was dramatically reduced (lane 3 in
Figure 6G). Coexpression of AS160 with the C-terminal region
of Fsp27 that lacked the AS160 interaction domain did not affect
the amount of Rab8a-GTP (lane 4 in Figure 6G). These data indi-
cate that the interaction between AS160 and Fsp27was required
for AS160 to act as a GAP for Rab8a to maintain its GDP-bound
and active form.
The Fsp27-dependent Rab8a GAP activity for AS160 promp-
ted us to check whether Fsp27, Rab8a, and AS160 form a
ternary complex by a two-step coimmunoprecipitation (coIP)
approach. In this experiment, Flag-tagged Rab8a, HA-tagged
AS160, and nontagged Fsp27 were coexpressed in 293T cells,
and Flag-tagged Rab8a was immunoprecipitated (1st step
coIP). The coIP components were then eluted with the FlagFigure 4. Fsp27 Preferentially Binds to Rab8a-GDP
(A) Rab8a interacts with Fsp27 in adipocytes. Rab8a protein from 8 day differenti
(B) Rab8a interacts directly with Fsp27 in vitro. MBP-Fsp27 (orMBP) andGST-Rab
pulled down using glutathione beads. MBP-Fsp27DTM represents truncated Fsp
(C) Fsp27 has higher affinity to the GDP-bound Rab8a in vitro. Data represent m
(D) Fsp27 interacts with GDP-bound Rab8a (T22N) with higher affinity when coe
(E) Rab8a interacts with the C-terminal region of Fsp27. L, light chain.
(F) C-terminal region (aa 136–239) of Fsp27 interacts with GDP-bound Rab8a (T2
(G) Schematic diagram showing conserved amino acid residues (R69, F70, I73) at t
(top panel). Amino acid substitutions for R69, F70, I73 (all to A, RFIA) of Rab8a dis
(H) RFIA was not localized to LDs when coexpressed with Fsp27. Scale bars rep
(I) RFIA has no activity in promoting Fsp27-dependent lipid exchange. Data repr
See also Figure S4.
386 Developmental Cell 30, 378–393, August 25, 2014 ª2014 Elseviepeptide and immunoprecipitation was carried out for the second
round using anti-HA antibody. Fsp27 and AS160 were found to
be present in the final immunoprecipitated products (Figure 6H),
indicating that these proteins are present in the same complex.
As a control, Rab18 was not able to pull down either Fsp27 or
AS160 (Figure 6H). Consistent with their complex formation,
Fsp27, Rab8a-GDP, and AS160 were colocalized at the LDCS
(Figure 6I). Interestingly, we observed significantly enhanced
interaction between Rab8a and Fsp27 in the presence of wild-
type but not mutant AS160 where its GAP activity was disrupted
(R/K) (Figure 6J), indicating that spatially localized active AS160
is required for maintaining Rab8a in its GDP-bound form that
strengthens its interaction with Fsp27.
MSS4 Negatively Regulates Rab8a-Mediated LD Fusion
To identify other cellular factors that regulate Rab8a-mediated
LD fusion, we expressed Flag-23 strep-tagged Rab8a and sub-
jected the cell lysates to tandem affinity purification, followed
by mass spectrometry. MSS4, a previously known Rab8 inter-
action protein, was identified in the Rab8a immunoprecipitates
(Figure 7A). When coexpressed, Rab8a was able to pull down
MSS4 (Figure S7A). However, unlike AS160, MSS4 did not
interact with Fsp27 (Figure S7A) and was not localized to LDs
or enriched at the LDCS (Figure S7B).
Consistent with its interaction with Fsp27, MSS4 expression
was detected in adipose tissues (WAT and BAT, Figure S7C).
Knocking down MSS4 in 3T3-L1 adipocytes (Figure S7D) signif-
icantly increased the sizes of LDs (Figures 7B and 7C) and lipid
exchange activity (63% higher than that of control cells, Fig-
ure 7D). Knocking down Rabin8, a well characterized GEF for
Rab8a, did not affect LD sizes or lipid exchange in adipocytes
(Figures 7B–7D and S7D). The increase in LD sizes caused by
the depletion of MSS4 was reversed by knockdown of Rab8a
(Figures 7B, 7C, and S7D). Knocking down MSS4 in 3T3-L1 pre-
adipocytes that ectopically expressed Fsp27 also resulted in the
accumulation of larger LDs (Figures S7E and S7F). When intro-
duced into 3T3-L1 adipocytes, MSS4 was able to reduce LD
sizes (Figures S7GandS7H) and lipid exchange rates (Figure 7E).
Overexpression or knockdown of MSS4 in adipocytes did not
alter the expression levels of Fsp27, Rab8a, or AS160 (Figures
S7D, right panel, S7G, right panel, and S7H, right panel). Overall,
these data strongly indicate that MSS4 is a negative regulator of
LD fusion and growth in adipocytes.
When coexpressed with wild-type Rab8a, MSS4 abrogated
the activity of Rab8a in enhancing lipid exchange and stimu-
lating LD growth (Figures 7F and S7I), whereas coexpressionated 3T3-L1 adipocytes was immunoprecipitated (IP) by anti-Rab8a antibody.
8a (or GST) were incubated at an equimolar ratio in vitro andGST proteins were
27 that lacked the transmembrane domain (Daa 179–217).
ean ± SD (**p < 0.01).
xpressed in 293T cells. Data represent mean ± SD (***p < 0.001).
2N) at higher affinity.
he N terminus of Rab8a that mediates its interaction with downstream effector
rupted interaction between Rab8a and Fsp27 (bottom panel).
resent 5 mm.
esent mean ± SEM (*p < 0.05, **p < 0.01).
r Inc.
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Rab8a-AS160-MSS4 Pathway Controls LD Fusionof MSS4 and Rab8a-GDP did not affect its activity (Figures 7F
and S7I). Interestingly, a point mutation (F75A) in MSS4 that
disrupts its interaction with Rab8a (Zhu et al., 2001) (Figure 7G,
bottom panel) rendered MSS4 unable to inhibit Rab8a-medi-
ated LD growth (Figures 7G and S7J), suggesting that the inter-
action between MSS4 and Rab8a is required for MSS4 to
inhibit LD fusion. In the presence of MSS4, the interaction
between Optineurin and Rab8a was enhanced (Figure S7K),
suggesting that MSS4 is able to convert Rab8a into its GTP
bound form. MSS4 also inhibited the association between
Fsp27 and Rab8a in the presence of GTPgS (Figure S7L).
Overall, these data suggest that MSS4 acts as a negative
regulator of Rab8a by interacting with Rb8a and sustaining its
GTP-bound state.
DISCUSSION
Obesity and hepatic steatosis are characterized by excessive
fat storage and the accumulation of large LDs in adipose
tissues and liver. Fsp27, an important regulator of the develop-
ment of obesity and nonalcohol fatty liver disease, has been
shown to control LD growth through an atypical LD fusion pro-
cess. Here, we present multiple lines of evidence to show that
Rab8a plays a critical role in Fsp27-mediated LD fusion. First,
Rab8a is the only Rab among the 20 Rabs that promotes LD
fusion, as its depletion markedly reduces LD fusion activity in
both preadipocytes and mature adipocytes. Conversely, ectop-
ically expressed Rab8a greatly enhances LD fusion. The phys-
iological importance of Rab8a in modulating LD fusion was
further verified in the liver of ob/ob mice, as liver-specific
knockdown of Rab8a leads to a significant reduction of LD
sizes and lower hepatic lipid storage in ob/ob mice. Impor-
tantly, we observed that knockdown of Optineurin, a positive
effector of Rab8a that binds to Rab8a-GTP and mediates
vesicle trafficking, did not affect LD sizes and hepatic TAG
levels in the liver of ob/ob mice (data not shown). Although
we cannot formally rule out the possibility that Rab8a may con-
trol hepatic lipid storage through indirect regulation of vesicle
trafficking, we believe that the Fsp27-Rab8a-GDP should be
the most direct and important pathway controlling hepatic lipid
storage in ob/ob mice.Figure 5. AS160 Acts as a Rab8a GAP to Enhance LD Fusion
(A) Increased AS160 expression during the course of 3T3-L1 adipocyte different
(B and C) AS160 knockdown reduces the sizes of LDs (B) and the lipid excha
differentiated 3T3-L1 cells by electroporation for 72 hr. Scale bars represent 20
(D and E) Activity of wild-type AS160 and its mutants in regulating LD fusion in Fsp
that abolishes its GAP activity. 4P represents an AS160mutant harboring amino ac
2 mm. (D) Data represent mean ± SD. Data were collected from three independe
(F and G) The activity of AS160 in promoting LD fusion is dependent on Rab8a. (F
(G) Data represent mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
(H) Western blots showing protein levels of AS160, Fsp27, Rab8a, Perilipin (Plin
knockout mice (AS160/).
(I) White adipocytes from AS160-deficient mice (AS160/) were smaller than th
tissues (WAT) of wild-type and AS160 knockout mice. Scale bars represent 50 mm
type (As160+/+) mice and 530 cells from five AS160-deficient (AS160/) mice w
(J) Total amount of TAG from the WAT of AS160 knockout mice was lower than
(K) Reduced LD sizes inAS160-deficient primary adipocytes. Primary preadipocyt
to differentiate in vitro. LDs were labeled with Bodipy 556/568 (C12, red). Scale b
(L) Decreased lipid exchange rates in AS160-deficient adipocytes. Data represen
See also Figure S5.
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Rabs is active in promoting membrane trafficking, we observed
that introduction of Rab8a-GDP, but not Rab8a-GTP, into Rab8a
depleted cells restored the ability of Rab8a to enhance LD fusion.
In addition, Rab8a-GDP is highly associated with LD and en-
riched at the LDCS in an Fsp27-dependent manner. Importantly,
Rab8a-GDP is not converted into its GTP form when it associ-
ates with LDs. Furthermore, Fsp27 and Rab8a form a complex
and Rab8a-GDP shows higher binding affinity for Fsp27 than
that of Rab8a-GTP. The functional correlation of Fsp27 and
Rab8a interaction is further strengthened by the identification
of the crucial amino acids residues on Rab8a that are required
for mediating its interaction with Fsp27 as mutations at these
residues disrupted Rab8a/Fsp27 association, its association
with LDs, and its LD fusion activity.
It is intriguing to identify a positive role of Rab8a-GDP in con-
trolling LD fusion as in the conventional RabGTPase pathway,
Rab-GTP is usually the active form that interacts with the down-
stream effector to control membrane dynamics. Although the
precise mechanism of Rab8a-GDP in controlling LD fusion re-
mains to be elucidated, we propose three possible models to
explain this activity. First, Rab8a-GDP interacts with down-
stream effector that is a positive regulator in LD fusion. A positive
role has been reported for the GDP-bound form of RagC/D as
RagC/D-GDP interacts with mTORC1 to promote the translo-
cation of mTORC1 to the lysosomal surface (Tsun et al., 2013).
Second, Rab8a-GTP may associate with a putative inhibitor of
LD fusion, and Rab8a-GDP disrupts this association, removing
the inhibition to promote LD fusion. However, we have shown
that overexpression of Rab8a-GTP (Q67L) did not inhibit
Fsp27-mediated LD fusion activity. These data do not support
a negative role of Rab8a-GTP in controlling LD fusion. Finally,
it is possible that Rab8a-GDP binds to and inhibits an LD-asso-
ciated GEF for an as-yet-unidentified small G protein that acts
in the same cascade for LD fusion.
In accordance with the observation that Rab8a-GDP is active
in promoting LD fusion, we observed that AS160, a GAP of
Rab8a, positive regulates LD fusion as knocking down or knock-
ing out AS160 abrogates the activity of Rab8a in enhancing
LD fusion, whereas its overexpression enhances LD fusion. We
also observed that the GAP activity of AS160 is required for itsiation.
nge rate (C) in 3T3-L1 adipocytes. AS160 siRNAs were delivered into 7 day
mm. Data represent mean ± SEM (**p < 0.01).
27-positive cells. R/K represents an AS160 mutant with Arg973 changed to Lys
id substitutions at Ser319, Ser588, Ser642, Ser751 to alanine. Scale bar represents
nt experiments. (E) Data represent mean ± SEM (*p < 0.05, **p < 0.01).
) Data represent mean ± SD. Data were from three independent experiments.
1), and FABP4 in the white adipose tissue of wild-type (AS160+/+) and AS160
at of wild-type (AS160+/+) mice. Left: Toluidine blue staining of white adipose
. Middle: data represent mean ± SD (*p < 0.05). Right: 259 cells from four wild-
ere measured.
that of wild-type mice. Data represent mean ± SD (*p < 0.05).
eswere isolated fromwild-typemice orAS160-deficient mice and then induced
ar represents 20 mm.
t mean ± SEM (**p < 0.01).
r Inc.
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Rab8a-AS160-MSS4 Pathway Controls LD Fusionfunction in stimulating LD fusion. Interestingly, we observed that
insulin did not affect LD fusion in adipocytes. Consistent with
this, mutated AS160 harboring substitutions at the AKT-induced
phosphorylation sites is still active in controlling LD fusion. This
is in contrast to insulin-dependent GLUT4 translocation that
depends upon the phosphorylation of AS160 by AKT. Mechanis-
tically, AS160 is localized to LDs, enriched at LDCS, and forms
a tripartite complex with Fsp27 and Rab8a. Importantly, the
interaction between AS160 and Fsp27 is required for AS160 to
act as a GAP of Rab8a. It is likely that Fsp27 acts as a bridge
by interacting with AS160 at the N terminus and Rab8a at the
C terminus to recruit them to the LDCS. Localized AS160 helps
to convert Rab8a-GTP into Rab8a-GDP and stabilize Rab8a in
the GDP-bound active form to facilitate LD fusion.
Finally, we have identified MSS4 as a negative regulator of
LD fusion and this activity is dependent on its interaction with
Rab8a. It is worth mentioning that Rabin8, a well-established
GEF of Rab8a, did not play a role in regulating LD fusion. There-
fore, it is unlikely that MSS4 plays a role as a typical GEF of
Rab8a to simply convert Rab8a-GDP to Rab8a-GTP. It is
possible that when MSS4 binds to Rab8a, it helps to maintain
Rab8a in a nucleotide-free configuration, sequestering it from
GTP/GDP binding cycle and inhibits its activity in LD fusion.
Based on the above evidence, we propose a model to explain
how the small GTPase regulatory loop, comprised of Rab8a,
AS160, and MSS4, regulate LD fusion. Fsp27 acts as an anchor
to recruit AS160 and Rab8a through their physical interaction to
LDCS, where AS160 stimulates the conversion of Rab8a-GTP to
Rab8a-GDP and thus stabilizes Rab8a in the GDP-bound active
form to facilitate LD fusion. As a negative regulator in the regula-
tory loop, MSS4 decreases the level of Rab8a-GDP and inhibits
LD fusion (Figure 7H). At the LDCS, Rab8a-GDP may recruit
other factors that facilitate fusion pore formation and LD fusion.
Alternatively, when bound to Rab8a-GDP, Fsp27 may adopt a
favorable conformation to induce LD fusion. The delineation of
the Rab8a-Fsp27-AS160-MSS4 regulatory circuit holds promise
for them to be molecular targets for developing therapeutic
drugs for the treatment of obesity and fatty liver disease. It is
also tempting to speculate that the Rab8a-AS160-MSS4 regu-
latory loop may be the converging point for various signaling
pathways in regulating the development of human obesity and
fatty liver disease.Figure 6. AS160 Interacts with Fsp27 and Is Enriched at LDCS
(A) Endogenous AS160 (green) in 3T3-L1 adipocytes is associated with LDs. Cells
3D-SIM. Scale bars represent 5 mm.
(B) AS160 is present in LD fraction of differentiated 3T3-L1 adipocytes. Five micro
were used as LD marker and cytosol marker, respectively. Calnexin and p58 we
(C and D) AS160 and Fsp27 form a complex in 3T3-L1 adipocytes. AS160 (C) or F
(E) Full-length and truncated Fsp27 (aa 1–153) interact with AS160. L, light chain
(F) Interaction between AS160 and Fsp27 is required for AS160 to enhance Rab8a
Rab8a stable knockdown cells. Data represent mean ± SEM (*p < 0.05).
(G) Interaction between AS160 and Fsp27 is required for AS160 to convert Rab8
(H) Two-step coimmunoprecipitation of complex containing Fsp27, AS160, and Ra
assay. Flag-Rab8a or Flag-Rab18 (as a control) was transfected into 293T cells w
(I) AS160, Rab8a-GDP, and Fsp27 were colocalized at the LDCS. 3T3-L1 adipo
Q67L). Cells were stained with antibodies against Flag (red) and endogenous AS16
interest are shown. Scale bars represent 5 mm.
(J) Wild-type (WT) but not the GAP-deficient mutant (R/K) of AS160 promotes the
See also Figure S6.
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Details for plasmids, antibodies, reagents, cell culture and transfection, RNAi,
immunofluorescent staining and 3D imaging, live cell imaging, protein purifica-
tion, coIP, GST pull-down, mass spectrometry, FRET, and lists of primers and
siRNAs are described in the Supplemental Experimental Procedures. The
laboratory animal facility in Tsinghua University has been accredited by the
Association for Assessment and Accreditation of Laboratory Animal Care
International (AAALAC) and the Institutional Animal Care and Use Committee
(IACUC). All animal protocols were approved by animal facility in Tsinghua
University.
Measurement of LD Sizes
Quantitative analysis of LD size in 3T3-L1 preadipocytes or adipocytes was
described by Sun et al. (2013b). For quantitative analysis of cells containing
large LDs, plasmids DNA or siRNAs were introduced into 3T3-L1 preadipo-
cytes through Amaxa nucleofection using program A-033 24 hr prior to
Fsp27 transfection. Cells were incubated with 200 mM OA complexed to
albumin for 15 hr, fixed, and stained with Bodipy 493/503. The percentage
of cells containing at least one LD larger than 2.0 mm in diameter was calcu-
lated. Approximately 200–300 cells from three independent experiments
were analyzed. To measure the LD size in differentiated 3T3-L1 adipocytes,
differentiated cells that were electroporated with indicated plasmids or siRNA
were fixed and stained with Bodipy 493/503. The diameter of largest LD in
one cells were measured. At least 150 cells were analyzed in each condition.
Images were obtained under an inverted microscope Axiovert 200M (Carl
Zeiss) or LSM710 confocal microscope (Carl Zeiss).
Calculation of Neutral Lipid Exchange Rate
Calculation of lipid exchange rate were essentially the same as previously
described (Gong et al., 2011; Sun et al., 2013b). In brief, 3T3-L1 preadipo-
cytes or differentiated 3T3-L1 adipocytes transfected with indicated plas-
mids or siRNAs were incubated with 200 mM OA and 1 mg/ml Bodipy 558/
568 C12 fatty acid (Molecular Probes) for 15 hr and changed to fresh me-
dium 1 hr before the experiment. Live cells were viewed under a confocal
microscope (LSM710) using a 633 oil immersion objective. LD pairs were
selected for bleaching. Selected regions were bleached by 500 interactions
at 100% laser power (543 diode laser), followed by time-lapse scanning with
a 12.5 s interval. Mean optical intensity (MOI) within LD core regions were
measured simultaneously. Approximately 20 pairs of LDs were analyzed
in each experiment. To obtain fluorescence recovery curves, MOI values
were calculated as the percentage of the original fluorescent intensity and
plotted using Prism 5.
TAG Measurement
The method for measuring hepatic TAG content was essentially the same as
described previously (Toh et al., 2008). For quantitative analysis, the hepatic
TAG spots of the samples and TAG standard on the TLC plates (Sigma)were stained with antibody against AS160 and Plin1. Images were analyzed by
grams of each sample was used for western blot analysis. CGI58 and b-tubulin
re used as microsomal markers.
sp27 (D) proteins in differentiated 3T3-L1 adipocytes were immunoprecipitate.
.
activity in promoting lipid exchange rates. Plasmid DNAs were transfected into
a from GTP to GDP bound form.
b8a. Top: schematic showing procedures for two-step coimmunoprecipitation
ith HA-AS160 and untagged Fsp27.
cytes were cotransfected with Fsp27-GFP (green) and Flag-Rab8a (T22N or
0 (blue). Z stack images were acquired. Orthographic projections of a region of
interaction between Rab8a and Fsp27. Data represent mean ± SD (**p < 0.01).
r Inc.
Figure 7. MSS4 Negatively Regulates Rab8a-Mediated LD Fusion
(A) MSS4 was identified in the Rab8a immunoprecipitated protein complex by mass spectrometry (MS).
(B and C) Knockdown of MSS4 (siMSS4) increases the sizes of LDs in wild-type but not in Rab8a knockdown adipocytes. siRNAs were delivered into 6 day
differentiated 3T3-L1 cells by electroporation for 48 hr. Boxed areas are shown at higher magnification at the bottom of every image. Scale bars represent 20 mm
(***p < 0.001).
(legend continued on next page)
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levels were normalized to the protein concentration of each sample.
Isolation of LD Fraction
LDs were purified according to the method as previously described (Bartz
et al., 2007) with slight modifications. In brief, 8 day differentiated 3T3-L1
adipocytes or 293T cells expressing with Fsp27 and Rab8a were harvested,
washed with PBS and resuspended in TES buffer (20 mM Tris [pH 7.4],
1 mM EDTA, and 250 mM sucrose). Cells were homogenized through Dounce
homogenizer with loose pestle for 25 times. The post nuclear supernatant
after centrifugation at 1,000 3 g was laid with floating buffer (100 mM NaCl,
20 mM Tris [pH 7.4], and 1.5 mM MgCl2) and centrifuged at 200,000 3 g for
1 hr. The pellet and middle gradient were collected as total membrane and
cytosol, respectively. The LD fraction on the top of the gradient was collected
and refloated using the two-layer gradient mentioned above for another
30 min at 200,0003 g. All procedures were performed at 4Cwith the addition
of protease inhibitor cocktails (Roche). Protein concentration was determined
using Bradfold method (Bio-Rad).
Liver-Specific Knockdown of Rab8a by Adenovirus Infection
Adenovirus carrying small hairpin RNA (shRNA) against Rab8a or scramble
shRNA were generated and amplified in AD293 cells using AdEasy-1 system
(Stratagene). The viruses were purified using CsCl density gradient centrifu-
gation, dialyzed against PBS. Viruses were injected into 3-month-old ob/ob
or wild-type mice via the tail vein at a dosage of 1 3 1012 pfu/mouse.
Animals were killed 10 days after injection and organs were taken for further
analysis.
Glucose and Insulin Tolerance Tests
Glucose (GTT) and insulin tolerance tests (ITT) were carried out by intraperito-
neal injection of glucose (1.0 g per kg of body weight) and recombinant human
insulin (0.5 unit per kg body weight) into fasting mice (16 hr or 4 hr for GTT and
ITT, respectively). We took tail blood samples before (0 min) and 15, 30, 60, 90,
and 120 min after injection, to measure glucose levels. Glucose levels were
measured by a blood glucose meter (Roche).
Statistics
Data from at least three independent experiments were subjected to statistic
analysis and plotted using Prism software (version 5.0; GraphPad Software).
Results were reported by mean ± SD or mean ± SEM, as indicated in the figure
legends. Single comparisons were performed using the Student’s t test
(version 5.0; GraphPad Software). Statistical difference was shown as *p <
0.05, **p < 0.01, ***p < 0.001. NS represents no statistical significant
difference.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2014.07.005.(D) Knockdown of MSS4 increases lipid exchange in adipocytes. siRNAs were
Data represent mean ± SEM (*p < 0.05).
(E) Overexpression of MSS4 decreases lipid exchange activity in adipocytes. GFP
were labeled with Bodipy 558/568 C12 (Red). Mean of intensity (MOI) in bleached (
of the initial intensity. Scale bars represent 5 mm. Data represent mean ± SEM (*
(F) Overexpression of MSS4 abrogates Rab8a but not Rab8a T22N’s activity in pr
(*p < 0.05, ***p < 0.001).
(G) Interaction between MSS4 and Rab8a is required for MSS4 to inhibit Rab8a
(F75A) has no activity in inhibiting Rab8a function. Data were from three indepe
munoprecipitation showing decreased interaction between Rab8a and MSS4 (F7
(H) A model depicting the role of Rab8a, AS160, and MSS4 in regulating LD fusio
AS160, as aGAP of Rab8a, converts Rab8a-GTP to Rab8a-GDP at the LDCS.MSS
reduces the amount of Rab8a-GDP and inhibits its activity in promoting LD fusio
See also Figure S7.
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